Analyst Downgrades: Peabody Energy, Macrocure, Twitter

Analysts are weighing in on mining firm Peabody Energy Corporation (NYSE:BTU), biotech Macrocure Ltd (NASDAQ:MCUR), and social media stock Twitter Inc (NYSE:TWTR). Here's a quick roundup of today's bearish brokerage notes on BTU, MCUR, and TWTR.

• BTU has managed to add 0.3% at $16.93 this morning, despite price-target cuts at Jefferies (to $20) and Citigroup (to $44). This is unusual technical strength from a stock that was down more than 85% in 2015 before today's open. Unfortunately, more bearish analyst attention could be forthcoming for the shares. Despite Peabody Energy Corporation's pitiful technical performance, four analysts still rate the equity a "strong buy."


• MCUR is getting smashed this morning, dropping 64.8% to hit $1.50 -- an all-time low -- after its specialty wound drug, Curexcell, failed a late-stage study. The stock has already underperformed the S&P 500 Index (SPX) by nearly 70 percentage points during the past three months, and now analysts are hitting the bricks. Jefferies and Credit Suisse lowered their price targets to $1.50 and $1, respectively, in response to the news.


• TWTR is in the midst of another post-earnings sell-off. The stock has dropped 10.6% to $27.99. The company's third-quarter profits were solid, but a lower-than-expected current-quarter forecast is weighing on the shares. Not to mention, no fewer than 20 brokerage firms lowered their price targets on the stock, with Evercore ISI setting the bar the lowest at $25. Twitter Inc isn't out of the woods yet, though. Ten brokerage firms still maintain "strong buy" opinions on the stock, while its consensus 12-month price target of $37.62 represents a 34% premium to current levels.